You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Roche’s SMA treatment Evrysdi demonstrates continued improvements in infants

Roche’s spinal muscular atrophy (SMA) treatment Evrysdi has continued to demonstrated improvements in motor function and survival in babies, according to new long-term data.